NASDAQ
American Bio Medica Corporation (ABMC) has a price/fcf ratio of -0.34x as of Tuesday, May 26, 2026. This represents a 107.31% decrease compared to its 12-month average of 4.71x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.